KEYNOTE SPEAKERS
|
|
|
|
SCOTT GOTTLIEB, M.D.
Immediate Past Commissioner Food and Drug Administration (2017-2019); Former Senior Advisor – CMS
|
DR. MICHELLE MCMURRY-HEATH
President & CEO,
Biotechnology Innovation Organization
|
In a year marked by unexpected challenges and rapid change, staying connected with industry peers and keeping a watchful eye on market trends, policy developments and collaborations in the life sciences space is crucial to bringing innovations to market.
Join us virtually for our signature Life Sciences Dealmaking Symposium, where seasoned dealmakers, industry executives and technical experts come together with McDermott's leading life sciences lawyers. Beginning October 20, we'll bring you a series of three pre-Symposium programs focused on today's most pressing concerns for life sciences dealmakers, all culminating in a half-day virtual program with multiple networking sessions, industry-leading keynote speakers and insights from investors, life sciences executives, policy experts and investment bankers.
PROGRAM DETAILS
PRE-SYMPOSIUM WEBINARS
Part 1: Tuesday, October 20, 12:00 – 1:00 pm EDT
- New Factors in the Mix: Diligence in the Time of COVID-19
Moderator:
Michael Siekman
Partner, McDermott Will & Emery
Anna French
Principal, Qiming Venture Partners
Tom Brida
General Counsel, Chief Compliance Officer, Invitae
Jennifer Bock
Attorney, McDermott Will & Emery
Laura Jehl
Global Head of Privacy and Cybersecurity Practice, McDermott Will & Emery
Chuck Wilson
President and CEO, Cogent Biosciences
Part 2: Tuesday, October 27, 12:00 – 1:00 pm EDT
- Powering Through the Pandemic: Trends in Early Stage Investment
Moderator:
Todd Finger
Partner, McDermott Will & Emery
Joanna Lin
Partner, McDermott Will & Emery
Marian Nakada
Vice President, Venture Investment, J&J Innovation
Andrew ElBardissi
Partner, Deerfield Management
Stacey Seltzer
Partner, Aisling Capital
Part 3: Tuesday, November 10, 12:00 – 1:00 pm EST
- As the Dust Settles: Post Election Update and Impact on the Life Sciences Industry
Moderator:
Eric Zimmerman
Global Head of Health Practice, McDermott Will & Emery
Rodney Whitlock, Ph.D.
Vice President, McDermott+Consulting
Brian Fortune
Senior Managing Director, Farragut Square Group
Susan van Meter
Executive Director, AdvaMedDx
Virtual Life Sciences Dealmaking Symposium: Tuesday, November 17, 8:00 am – 2:00 pm EST
*Networking platform will be open from 8:00 am - 6:00 pm EST*
AGENDA:
|
8:00 - 9:45 am
|
Pre-event Networking
|
|
9:30 – 9:35 am
|
Welcome Remarks
Krist Werling, Co-Chair, Life Sciences Industry Group, McDermott Will & Emery
|
|
9:35 – 10:00 am
|
Michelle McMurry-Heath Keynote
President and CEO, Biotechnology Innovation Organization
|
|
10:00 – 10:40 am
|
M&A Outlook: Expect the Unexpected
Moderator: Byron Kalogerou, Partner, McDermott Will & Emery
Dennis Crowley, Senior Vice President, Business Development & Licensing, Baxter
Patrice McNicoll, Co-head of Investment Banking, B. Riley Financial
|
|
10:40 – 11:10 am
|
Sight Unseen: Cross-border Collaboration Goes Virtual
Moderator: Emmanuelle Trombe, Partner, McDermott Will & Emery
Rich Smith, Partner, McDermott Will & Emery
|
|
11:10 – 11:15 am
|
Bio Break
|
|
11:15 – 11:45 am
|
Speed vs. Safety: Innovating with Urgency in Diagnostics & Vaccines
Moderator: Brian Malkin, Partner, McDermott Will & Emery
Steve Bossone, Senior Vice President, Chief Patent Counsel, Alnylam
Sarah Columbia, Partner, McDermott Will & Emery
Michael Ryan, Partner, McDermott Will & Emery
Alan Wright, Chief Medical Officer, Roche Diagnostics
|
|
11:45 am – 12:15 pm
|
Digital Health Takes Center Stage: Will It Be The Hottest Sector for Dealmaking
Moderator: Stephen Bernstein, Co-Chair, Life Sciences Industry Group, McDermott Will & Emery
Kathy Bergsteinsson, Managing Director, Morgan Stanley
Jennifer Geetter, Partner, McDermott Will & Emery
Debbie Lin, Executive Director, Boehringer Ingelheim Venture Fund
Rene Quashie, Vice President, Policy and Regulatory Affairs, Digital Health, Consumer Technology Association
|
|
12:15 – 12:45 pm
|
Racial Justice in the Start-up Sector: the McDermott RISE Program
Moderator: Vernessa Pollard, Chair, FDA Practice, McDermott Will & Emery
Marshall Jackson, Partner, McDermott Will & Emery
Nathan Pelzer, CEO, Clinify Health
Kwame Ulmer, Founder, MedTech Color
|
|
12:45 – 1:30 pm
|
Scott Gottlieb Keynote
Immediate Past Commissioner Food and Drug Administration (2017-2019); Former Senior Advisor – CMS
|
|
1:30 – 2:00 pm
|
Post-event Networking
|
View Full Agenda (Coming Soon)
